张文宏：科技创新不能止于论文，须落地消除全球健康不平等

Core Insights - The Global Health Innovation Institute has officially launched, aiming to address global health disparities and promote the translation of health products from laboratory to market, particularly for low- and middle-income countries [1][6] - The institute will focus on diseases such as tuberculosis and malaria, as well as women's and children's health, providing technical support and resources to facilitate innovation and market entry [6] Funding and Support - The initial five-year research funding for the Global Health Innovation Institute is jointly provided by the Shanghai municipal government and the Gates Foundation, with the latter offering project grants and technical support [2] Challenges in Disease Treatment - China faces significant challenges with infectious diseases like tuberculosis, with approximately 741,000 new cases reported in 2023, ranking third globally [4] - The treatment of drug-resistant tuberculosis is particularly difficult and costly, with treatment expenses often exceeding 150,000 yuan and requiring 18-20 months [4] Innovative Solutions - Zhang Wenhong's team is testing innovative treatment protocols in high-burden areas, aiming to reduce tuberculosis treatment costs by over 90% and achieve a cure rate of over 80% for multidrug-resistant cases [5] - The World Health Organization (WHO) emphasizes the need for ongoing research to support the effective implementation and promotion of clinical trial results [5] Resource Coordination - The Global Health Innovation Institute aims to integrate domestic research and production capabilities with international clinical and field validation resources, which are crucial for advancing global health products [1][6] - The institute will leverage Shanghai's talent pool, including public health experts and international cooperation specialists, to enhance its impact [6] Successful Case Studies - The Shanghai-based company Dahua has delivered over 6 million subdermal contraceptive implants to countries outside China from 2017 to 2022, significantly reducing unintended pregnancies and maternal deaths while saving $250 million in public health costs [7] - A malaria control demonstration project in Tanzania, initiated in collaboration with the Gates Foundation, has shown a decline in malaria prevalence in all intervention areas, with plans for expansion into other high-burden countries [7]